M. Argnani

Is There Any Difference in PBPC Mobilization Between Cyclophosphamide Plus G-CSF and G-CSF Alone in Patients with Non-Hodgkin's Lymphoma?

E. Scarpi, M. Marangolo, C. Dazzi, 2000, Leukemia & lymphoma.

Epirubicin + G-CSF as peripheral blood progenitor cells (PBPC) mobilising agents in breast cancer patients.

P. Morandi, G. Monti, G. Rosti, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

Peripheral blood progenitor cell (PBPC) mobilization in heavily pretreated patients with germ cell tumors: a report of 34 cases

M. Marangolo, G. Fiorentini, C. Dazzi, 1999, Bone Marrow Transplantation.

A randomized study comparing filgrastim versus lenograstim versus molgramostim plus chemotherapy for peripheral blood progenitor cell mobilization

E. Scarpi, M. Marangolo, B. Kopf, 2006, Bone Marrow Transplantation.

Multiple cycles of PBPC-supported high-dose carboplatin and paclitaxel following mobilization with epirubicin and cisplatin are feasible but ineffective in treating patients with advanced non-small cell lung cancer

M. Marangolo, B. Kopf, G. Ciucci, 2007, Bone Marrow Transplantation.

Salvage high‐dose chemotherapy in patients with germ cell tumors

M. Marangolo, U. de Giorgi, R. Salvioni, 2002, Cancer.

An Italian experience of high-dose chemotherapy and autologous bone marrow transplantation (ABMT) in germ cell tumours. Suggestions for future direction.

G. Fiorentini, R. Salvioni, A. Tienghi, 1992, Leukemia & lymphoma.